Whereas EGFR gene amplification and activating mutations in the receptor kinase domain are frequent in human CRC samples [171,172], experiments in mice showed that the EGFR activity is indispensable for tumors developed in Apc+/Min mice [170] or in AOM/DSS-induced neoplasia [168]. The gene discussed is EGFR; the disease is colorectal carcinoma.